NLRP3 and brain injury: Clemastine, as an antihistamine, has a positive anti-neuroinflammatory effect, could reduce the activation of microglia and down-regulate the expression of IL-1β and NLRP3 in rats with hypoxic-ischemic brain injury (Xie et al., 2020).